Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://journals.lww.com/ajsp/abstract/2011/06000/oncofetal_protein_imp3,_a_new_diagnostic_biomarker.13.aspx, but it redirected us to https://journals.lww.com/ajsp/abstract/2011/06000/oncofetal_protein_imp3,_a_new_diagnostic_biomarker.13.aspx. The analysis below is for the second page.

Title[redir]:
The American Journal of Surgical Pathology
Description:
as a biomarker to distinguish between malignant and reactive mesothelial cells. A total of 109 cases (mesothelioma, n=45; reactive mesothelial proliferation, n=64) were examined by immunohistochemistry for IMP3 expression. IMP3 showed strong cytoplasmic staining in 33 of 45 (73%) mesothelioma cases. In contrast, the expression of IMP3 was undetectable in all (64 cases) benign reactive mesothelial proliferations. Among the IMP3-positive mesotheliomas, 27 (82%) exhibited diffuse IMP3 expression. The vast majority of IMP3-positive subtypes of mesotheliomas showed IMP3 expression in >50% of malignant cells, as this diffuse staining pattern occurred in 17 (81%) cases of epithelial, 4 (100%) cases of sarcomatoid, and 6 (75%) cases of mixed types of mesothelioma. In addition, 2 cases, which were initially diagnosed as atypical mesothelial proliferations and later confirmed to be mesotheliomas, showed diffuse IMP3 expression. Our findings suggest that IMP3 is a new positive biomarker for malignant mesothelioma. IMP3 immunohistochemical staining can be used as an adjunct tool in the distinction of malignant mesothelioma from reactive mesothelial proliferations....

Matching Content Categories {📚}

  • Education
  • Mobile Technology & AI
  • Photography

Content Management System {📝}

What CMS is doi.org built with?


Doi.org is built with MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 76,504,851 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

imp, journal, mesothelioma, mesothelial, cases, malignant, reactive, expression, issue, proliferation, access, subscribe, alerts, articles, authors, abstract, protein, biomarker, showed, staining, proliferations, mesotheliomas, diffuse, log, register, logo, issues, oncofetal, distinguish, phd, surgical, buy, distinction, growth, factor, cells, benign, imppositive, immunohistochemical, text, subscribers, request, article, browse, content, submit, service, privacy, policy, secondary,

Topics {✒️}

0b013e318218985b buy abstract reactive mesothelial proliferation reactive mesothelial proliferations imp3 immunohistochemical staining journal authors submit full text access atypical mesothelial proliferations clonal cellular proliferation benign fibromatous tumors reactive mesothelial cells oncofetal protein read immunohistochemical expression prostatic carcinoma subsequent large-cell change artificial intelligence training imp3-positive subtypes imp3-positive mesotheliomas etoc alerts service request 800-638-3030 register subscribe individual subscribers log american journal journal tables imp3 expression distinguish malignant mesothelioma issue website subscribe journal malignant cells center submit positive biomarker karen bsc surgical pathology 35 major challenge surgical pathologists vast majority mixed types initially diagnosed findings suggest adjunct tool glycoprotein a-80 desmoid tumor pcr amplification paratesticular region email inbox rights reserved data mining min md peiguo md kristine md

Questions {❓}

  • Not a Subscriber?

Social Networks {👍}(1)

External Links {🔗}(63)

Analytics and Tracking {📊}

  • Comscore
  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Scite
  • Wolterskluwer

5.18s.